EcoDrugPlus

26s Proteasome Regulatory Subunit 8-Like

Ensembl ID : ENSOTSG00005043596
Gene Symbol: LOC112224068
3 Cross references
222 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSOTSG00005012207
Gene Symbol: HMGCR
1 Cross references
195 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase B

Ensembl ID : ENSOTSG00005036211
Gene Symbol: HMGCRB
1 Cross references
205 Possible Orthologues:

3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2-Like

Ensembl ID : ENSOTSG00005034919
Gene Symbol: LOC112265604
3 Cross references
202 Possible Orthologues:

3-Oxo-5-Alpha-Steroid 4-Dehydrogenase 2-Like

Ensembl ID : ENSOTSG00005027982
Gene Symbol: LOC112230405
3 Cross references
202 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1a

Ensembl ID : ENSOTSG00005030651
Gene Symbol: PDPK1A
1 Cross references
165 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1a

Ensembl ID : ENSOTSG00005047658
Gene Symbol: PDPK1A
1 Cross references
165 Possible Orthologues:

3-Phosphoinositide-Dependent Protein Kinase 1-Like

Ensembl ID : ENSOTSG00005044872
Gene Symbol: LOC112219534
3 Cross references
214 Possible Orthologues:

3-Phosphoinositide-Dependent Protein Kinase 1-Like

Ensembl ID : ENSOTSG00005005023
Gene Symbol: LOC112223683
3 Cross references
214 Possible Orthologues:

3-Phosphoinositide-Dependent Protein Kinase 1-Like

Ensembl ID : ENSOTSG00005001740
Gene Symbol: LOC112219534
3 Cross references
214 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase-Like

Ensembl ID : ENSOTSG00005023157
Gene Symbol: LOC112249674
3 Cross references
198 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase-Like

Ensembl ID : ENSOTSG00005030710
Gene Symbol: LOC112263009
3 Cross references
198 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).